BVGH strategically develops and manages programs across the for-profit and non-profit sectors to catalyze innovative research and development (R&D); expand research and healthcare …

Advancing Health Equity by Reducing the Burden of Infectious Diseases Low- and middle-income countries (LMICs) can only attain health equity by eliminating their disproportionate burden of …

BIO Ventures for Global Health (BVGH) is a nonprofit organization based in Seattle, Washington working at the crossroads of the private and public sectors to sustainably foster innovation …

Building clinical and research capacity are pillars of BVGH’s primary programs, African Access Initiative and Global Innovation Alliance. We aim to share knowledge in areas prioritized by the …

Innovative Approaches to Cancer Training in Africa Through the African Access Initiative (AAI), BIO Ventures for Global Health (BVGH) is addressing Africa’s cancer crisis by gathering data …

Cancer Programs: Africa is facing a growing cancer crisis, with the annual burden of disease expected to reach 2 million new cases and 1.4 million deaths by 2040. BVGH unites African …

Infectious Disease Programs: Infectious diseases disproportionately burden people living in low- and middle-income countries (LMICs). BVGH forges and manages multinational public-private …

AC 3 T Site Map Enrollment in high-quality clinical trials is critical for ensuring that medicines, technologies, and practices are safe and effective in all patient populations – including the …

ESTERN ESERVE UNIVERSITY Hansen Research Institute P Alnylam Finder 'Alnylam Merck KGaA Darmstadt, Germany MSD Be well SANOFI O GlaxoSmithKline NOVARTIS *Known as …

Home About Our Team African Access Initiative Global Innovation Alliance African Consortium for Cancer Clinical Trials BVGH Learn Let’s Talk About Cancer News and Publications …